Archive for September, 2010

FOR THOSE INTERESTED in the Lyme communities well-being please join us in supporting the IOM Lyme Disease workshop.  WE MUST begin somewhere by coming forth as an objective working “team” who want help for those suffering with this horrific disease.  Will it work?  We don’t know, but it shows good faith that we are willing to work together to find the much needed answers.  Lymies need to UNITE and begin working together and stop the inter-bickering that has gone on for the 10 years I have been around.  The organizations and individual listed below are willing to give it a try and support our presenters.  Please share this message with all you know.

Regards,

Linda Heming      

CHOICE=Consumers of Healthcare Options with Independence Choice and Experience                       

LymeAngl@aol.com

September 23, 2010

Dear Lyme Community:

As you know, some Lyme advocates have chosen to pull out of the IOM Lyme Disease workshop http://www.iom.edu/Activities/Disease/TickBorne.aspx. They are legitimately concerned that the agenda is heavily biased against the patients’ interest.  We respect their concerns and their decision to pull out of the workshop.  However, upon careful consideration, we have decided to participate in the IOM workshop to represent the Lyme patient’s perspective and show support for our presenters.  While we have our own reservations, we are working hard to improve the agenda.

Here are some facts and thoughts to consider in making your own decision:

1)  The IOM Lyme workshop is not a forum to debate whose science is right or wrong.  It is, rather, an assessment of the state of the science as presented from all points of view, for the purpose of determining the science and research still needed.  This workshop is not designed to draw conclusions, but to determine where future research needs to go.

2)  If Lyme patients and Lyme doctors fail to participate, the only perspective presented will be that of the IDSA.  If our Lyme doctors and advocates don’t participate, the committee can’t include them in the record and it will appear in the report as if we don’t exist or care.

3)  The IOM committee will accept comments for the record up to 3 or 4 days after the workshop.  If you don’t know what was said at the workshop, you cannot draw intelligent comments.

4)  Clinicians will have a microphone reserved solely for their use, with extra time allocated to their questions or comments which will be included in the final report. Lyme doctor participation is critical or the IDSA clinicians will be the only ones at the microphone and on record.

5)  A Congressman worked hard for the appropriation to fund this project. Abandoning this workshop is abandoning him, and will compromise his future ability to argue successfully for Lyme patients in Congress. This Representative needs Lyme community support at this workshop. We cannot “burn our Congressional bridges” with the very people who are critical to our cause.

6)  When you withdraw from the Washington process, you won’t be asked back again. Each time this happens, we lose our ability to be taken seriously.  History shows that progress is made when we work within the system, not when we abandon it. Admittedly, it is by nature, a long and arduous process.

Bottom line: the workshop will proceed with or without our community; without representation we concede to the IDSA.  We can’t let that happen!  If the situation warrants it, there will be time to write a minority report.

Please attend this workshop and explain your views on the gaps in science and the research you think is needed.  For example, the gaps in diagnosis that caused your disease to go unrecognized; the lack of uniformity in approaches of the states; the problem of underreporting; the unreliability of testing and the other issues you believe should be addressed by the science.

Thank you,

Full article: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=20180313&retmode=ref&cmd=prlinks

Excerpt:

Ticks harbor numerous bacterial, protozoal, and viral pathogens
that can cause serious infections in humans and domestic animals.
Active surveillance of the tick vector can provide insight into
the frequency and distribution of important pathogens in the
environment. Nucleic-acid based detection of tick-borne
bacterial, protozoan, and viral pathogens requires the extraction
of both DNA and RNA (total nucleic acids) from ticks. Traditional
methods for nucleic acid extraction are limited to extraction of
either DNA or the RNA from a sample.
Here we present a simple bead-beating based protocol for
extraction of DNA and RNA from a single tick and show detection
of Borrelia burgdorferi and Powassan virus from individual,
infected Ixodes scapularis ticks. We determined expected yields
for total nucleic acids by this protocol for a variety of adult
tick species. The method is applicable to a variety of arthropod
vectors, including fleas and mosquitoes, and was partially
automated on a liquid handling robot.

Full article: Central Figure in CDC Vaccine Cover-Up Absconds With $2M

Excerpt:

A central figure behind the Center for Disease Control’s (CDC) claims disputing the link between vaccines and autism and other neurological disorders has disappeared after officials discovered massive fraud involving the theft of millions in taxpayer dollars. Danish police are investigating Dr. Poul Thorsen, who has vanished along with almost $2 million that he had supposedly spent on research.

Thorsen was a leading member of a Danish research group that wrote several key studies supporting CDC’s claims that the MMR vaccine and mercury-laden vaccines were safe for children. Thorsen’s 2003 Danish study reported a 20-fold increase in autism in Denmark after that country banned mercury based preservatives in its vaccines. His study concluded that mercury could therefore not be the culprit behind the autism epidemic.

His study has long been criticized as fraudulent since it failed to disclose that the increase was an artifact of new mandates requiring, for the first time, that autism cases be reported on the national registry. This new law and the opening of a clinic dedicated to autism treatment in Copenhagen accounted for the sudden rise in reported cases rather than, as Thorsen seemed to suggest, the removal of mercury from vaccines. Despite this obvious chicanery, CDC has long touted the study as the principal proof that mercury-laced vaccines are safe for infants and young children. Mainstream media, particularly the New York Times, has relied on this study as the basis for its public assurances that it is safe to inject young children with mercury — a potent neurotoxin — at concentrations hundreds of times over the U.S. safety limits.

Excerpt:

89 cases of neuroborreliosis were reported; in 66 cases diagnosis was confirmed. Facial weakness was one of the presenting symptoms in 47 cases (71%) and the only symptom in nine children (14%). The five complaints most frequently reported were: malaise, headache, fatigue, fever and neck pain. 52 children (79%) had one or more objective neurological signs at presentation, of which facial nerve palsy, other cranial nerve abnormalities and meningeal signs were most frequent. 14 patients (21%), however, had no neurological signs at physical examination. In these patients, the number of subjective complaints was higher, and the time interval to diagnosis was longer compared with those with objective neurological abnormalities.

Conclusions

In this study, 79% of paediatric neuroborreliosis patients presented with neurological signs, most often facial nerve palsy. 21% presented in an atypical way without neurological signs. A thorough neurological examination is essential once neuroborreliosis is considered in children. Even in the absence of neurological signs, neuroborreliosis may be suspected in children with typical antecedents and multiple symptoms. Cerebrospinal fluid investigations are then required to confirm the diagnosis.

Full article: http://www.biomedcentral.com/1471-2334/10/229

Excerpt:

Results

Following inoculation with B. tamiae, mice developed ulcerative skin lesions and subcutaneous masses on the lateral thorax, as well as axillary and inguinal lymphadenopathy. B. tamiae DNA was found in subcutaneous masses, lymph node, and liver of inoculated mice. Histopathological changes were observed in tissues of inoculated mice, and severity of lesions correlated with the isolate inoculated, with the most severe pathology induced by B. tamiae Th239. Mice inoculated with Th239 and Th339 demonstrated myocarditis, lymphadenitis with associated vascular necrosis, and granulomatous hepatitis and nephritis with associated hepatocellular and renal necrosis. Mice inoculated with Th307 developed a deep dermatitis and granulomas within the kidneys.

Conclusions

The three isolates of B. tamiae evaluated in this study induce disease in immunocompetent Swiss Webster mice up to 6 weeks after inoculation. The human patients from whom these isolates were obtained had clinical presentations consistent with the multi-organ pathology observed in mice in this study. This mouse model for B. tamiae induced disease not only strengthens the causal link between this pathogen and clinical illness in humans, but provides a model to further study the pathological processes induced by these bacteria.

Linda’s comment: 

IV Vitamin C will also work on West Nile Virus.  I have suggested that ALL of my readers stock up your medicine cabinets with BioEn’R-Gy and ACS200ppm.  I know Dr Ber personally and he saved 20 plus people one year from West Nile Virus.  It is tough to get the allopathic docs to open up their eyes and step outside of the box.

Dr. Gordon’s Comment:

IV Vitamin C is now proven effective against Swine Flu but why not also have the best tolerated oral form of  vitamin C available anywhere on hand, BioEn’R-G’y, in your patients homes along with the most powerful colloidal silver  available anywhere, ACS 200.  Nothing compares to the proven killing power of ACS 200.   

Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com 

Full article: http://www.3news.co.nz/Living-Proof/tabid/371/articleID/171328/Default.aspx

Excerpt:

Hello,

I would like to submit a case report of a nearly terminal case of swine flu completely cured in short order by vitamin C. The doctors in the FACT group are very aware individuals, and they collectively have many brilliant and innovative ways to approach treating their patients. However, I want to make it clear that adequately dosed vitamin C, to my knowledge, has never failed to cure an acute viral syndrome. Specifically, all these doctors should now realized that H1N1, the swine flu virus, while perhaps proving to be more potent than a host of other flu viruses, need not be a feared bogeyman with vitamin C in their arsenal.

While I intend to assemble a more substantial case report from the hospital chart in the future, here are the words of my colleague in New Zealand, John Appleton:

“The short story is:

Waikato farmer goes to Fiji for holiday
Starts developing flu like symptoms–decides to tough it out
Arrives back in NZ very sick–swine flu
Tauranga Hospital not able to treat him (what was not known at the time is that he has leukemia–he didn’t know either)
Sent him to Auckland Hospital–continues to deteriorate–Tamiflu–antibiotics etc. (usual stuff)
Brother-in-law (knows a bit about vitamin C) contacts Thomas Levy in the US who refers him to me
I provided a lot of info on vitamin C etc and referred family to CAM (Centre for Advanced Medicine) www.camltd.co.nz in Auckland
Family pushes to get him some IVC–hospital refuses
CAM doctors encourages hospital then to try vitamin C
Patient deteriorates further and is on life support–family told nothing more can be done and life support will be switched off on Monday. Lungs not functioning.
Family says NO–until everything has been tried–they won’t agree to life support being ‘switched off’.

Linda’s comments……I often wonder if some of the Cancers I had were not caused from all the chemo-drugs I handled….during the 60’s.  Osha did not have rules about having a hood for vapors in our Cancer clinics….When my immune took a dive and the Lyme moved in, is when the Cancers began to appear…..God Blessed me with the knowledge to move from allopathic medicine to the holistic/alternative world.  Holistic/Alternative medicine has saved my life on many occasions with the blessing from God.  This is an excellent article to show you how toxic the chemo drugs are and that there ARE alternatives….So much of the chemo drugs also cause many side effects and people die from the sides rather than the Cancers.

One of the side effects of chemotherapy is, ironically, cancer. The cancer doctors don’t say much about it, but it’s printed right on the chemo drug warning labels (in small print, of course). If you go into a cancer treatment clinic with one type of cancer, and you allow yourself to be injected with chemotherapy chemicals, you will often develop a second type of cancer as a result. Your oncologist will often claim to have successfully treated your first cancer even while you develop a second or third cancer directly caused by the chemo used to treat the original cancer.

There’s nothing like cancer-causing chemotherapy to boost repeat business, huh?

During all this, the pharmacists are peddling these toxic chemotherapy chemicals to their customers as if they were medicine (which they aren’t). While preparing these toxic chemical prescriptions, it turns out that pharmacists are exposing themselves to cancer-causing chemotherapy agents in the process. And because of that, pharmacists are giving themselves cancer… and they’re dying from it.

Why pharmacists are dying of cancer

People who live in glass houses should never throw stones, they say. And you might similarly say that pharmacists who deal in poison shouldn’t be surprised to one day discover they are killing themselves with it.

FOR THE REST OF THE ARTICLE GO TO: 
http://hfnn.ca/index.php?showArticle=14602

Full Article: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=20392886&retmode=ref&cmd=prlinks

Excerpt:

Neurobiology and Pain Therapeutics Section, Laboratory of Sensory
Biology, National Institute of Dental and Craniofacial Research,
Laboratory of Clinical Infectious Diseases, National Institute of
Allergy and Infectious Disease, National Institutes of Health,
Bethesda, MD 20892.

There is currently a need for improved serological tests for the
diagnosis and monitoring of Lyme disease, an infection caused by
Borrelia burgdorferi (Bb).
Here, we evaluated Luciferase Immunoprecipitation Systems (LIPS)
for profiling antibody responses to a panel of Bb proteins for
diagnosis of Lyme disease.
Initially, a training serum cohort of patients and controls
(n=46) was profiled using 15 different Bb antigen constructs. In
the patient sera, antibody responses to several Bb antigens
including VlsE, Flagellin (FlaB), BmpA, DbpA, and DbpB, showed
high levels of immunoreactivity. However, the best diagnostic
performance was achieved with a synthetic protein, designated as
VOVO, consisting of a repeated antigenic VlsE-OspC-VlsE-OspC
peptide sequence.

Full article: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=20695287&retmode=ref&cmd=prlinks

Excerpt:

We compared the application of IC2, a minimal-risk (25B)
botanical compound containing 10% rosemary oil, with bifenthrin,
a commonly used synthetic compound, and with water for the
control of Ixodes scapularis Say (= Ixodes dammini Spielman,
Clifford, Piesman & Corwin), on tick-infested grids in Maine, in
an area where Lyme disease is established and other tick-borne
diseases are emerging. High-pressure sprays of IC2, bifenthrin,
and water were applied during the peak nymphal (July) and adult
(October) seasons of the vector tick. No ticks could be dragged
on the IC2 grids within 2 wk of the July spray, and few adult
ticks were found in October or the following April. Similarly, no
adult ticks could be dragged 1.5 wk after the October IC2 spray,
and few the following April. No ticks were found on the
bifenthrin grids after either spray through the following April,
whereas substantial numbers of ticks remained throughout on the
grids sprayed with water. Thus, IC2 appears to be an effective,
minimum-risk acaricide to control the vector tick of Lyme
disease.

The epigenetic research is explained very well in the attached text from a video clip that I have put on the www.gordonresearch.com website. The pictures bring this to life and will be very educational to any audience but the conclusion from the video clip is below.

Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com

Full article: http://www.fliqz.com/aspx/permalink.aspxvid=75c53ffb47df42fb85809973823b249d

Excerpt:

Nova
A Tale of Two Mice
In this audio slide show, Dr. Dana Dolinoy of Duke University explains the role that the epigenome, a sort of second genome, plays in regulating the expression of our genes. As Dolinoy notes, we can no longer say with certainty whether genetics or the environment have a greater impact on our health, because the two are inextricably linked through the epigenome. Continued